Journal of Basic and Applied Research in Biomedicine https://jbarbiomed.com/index.php/home <p>The “Journal of basic and applied research in biomedicine” was first published in 2015 as “Journal of basic and applied research”. Since 2019, the title of the journal was changed to “Journal of basic and applied research in biomedicine”. It is an independent, international, double-blind peer-reviewed journal with a broad scope that cover all aspects related to biomedical sciences and human health. One volume (since 2023) is published every year and the manuscript is published in electronic format as soon as it is accepted. The journal is licensed under a Creative Commons Attribution 4.0 International License and all published articles are freely available.</p> Journal of Basic and Applied Research in Biomedicine en-US Journal of Basic and Applied Research in Biomedicine 2413-7014 Pseudomonas aeruginosa biofilm formation: Antibiofilm Strategies and conventional methods of evaluation. https://jbarbiomed.com/index.php/home/article/view/234 <p><em>Pseudomonas aeruginosa</em> is an opportunistic pathogen known for its ability to form resilient biofilms, which contribute to its persistence in chronic infections and resistance to antimicrobial agents. This review provides a detailed examination of biofilm development stages—attachment, maturation, and dissemination and highlights the role of specific genes in each stage, with a focus on quorum sensing as a key regulatory mechanism governing bacterial communication within biofilms. It also evaluates conventional methods for analyzing <em>P. aeruginosa</em> biofilm phenotypes, discussing their purposes, advantages, and limitations. Accordingly, future research should focus on standardizing protocols, advancing imaging technologies, and targeting biofilm-specific mechanisms. Collaborative efforts across disciplines and translational research will be essential for developing effective therapies. This review aims to deepen our understanding of <em>P. aeruginosa</em> biofilm dynamics and highlight the implications for developing effective therapies against biofilm-associated infections.</p> Sham Ma'aitah Copyright (c) 2024 Sham Ma'aitah https://creativecommons.org/licenses/by/4.0 2024-10-12 2024-10-12 10 1 11 28 10.51152/jbarbiomed.v10i1.234 Nanomaterials in Medicine: Advancing Drug Delivery, Diagnostics, and Therapeutics https://jbarbiomed.com/index.php/home/article/view/239 <p>Nanomaterials have revolutionized various fields of medicine, providing innovative solutions for drug delivery, diagnostics, vaccines, and regenerative therapies. The aim of this review is to explore the diverse applications of nanomaterials in medicine, highlighting their potential to enhance treatment efficacy, improve patient outcomes, and address complex medical challenges. Through successful applications like Doxil and Abraxane, nanotechnology has demonstrated its ability to improve targeted drug delivery, while lipid nanoparticles have played a pivotal role in the development of mRNA vaccines for COVID-19. Nanomaterials offer unique advantages, such as their small size, tunable surface properties, and the ability to cross biological barriers, which enable precision therapies and improved diagnostic sensitivity. However, this review also addresses the challenges associated with nanomaterials, including safety concerns, potential toxicity, long-term biodegradability, and the regulatory hurdles that must be overcome for clinical translation. As researchers work to develop biocompatible and biodegradable materials, new opportunities arise in personalized medicine, stimuli-responsive nanomaterials, and theranostics that combine diagnosis and therapy into a single platform. In conclusion, while nanotechnology in medicine offers immense potential for future medical innovations, addressing safety and regulatory challenges will be crucial for the broader adoption of nanomaterials in clinical practice. This review emphasizes the need for continued research and development to realize the full potential of nanomedicine in improving healthcare outcomes globally.</p> Nasreen Kader Copyright (c) 2024 Nasreen Kader https://creativecommons.org/licenses/by/4.0 2024-11-30 2024-11-30 10 1 29 49 10.51152/jbarbiomed.v10i1.239 Molecular Detection of Some Risk Factors of Thromboembolism among Nigerian Women on Hormonal Contraceptives https://jbarbiomed.com/index.php/home/article/view/230 <p>Hormonal contraceptives are commonly used by women of reproductive age and may be associated with an increased risk of thromboembolism. Any rise in the relative risk of venous thromboembolism related to specific contraceptive formulations could lead to a notably elevated absolute risk. This study seeks to evaluate the potential role of Factor V Leiden (FVL) and Prothrombin G20210A mutations as risk factors for thromboembolism in users of hormonal contraceptives in Benin City. The study population consisted of 50 non-contraceptive users, 50 non-hormonal contraceptive users, 50 progestin-only contraceptive users, and 50 combined oral contraceptive users recruited from Family Planning Clinics in Benin City. Each participant provided aseptically collected venous blood, with 5.0 mL collected in total. 0.5 mL was placed in a container containing 3.1% tri-sodium citrate anticoagulant for the manual determination of Prothrombin time (PT) and activated partial thromboplastin time (APTT). Additionally, 0.5 mL of venous blood was dispensed into a plain container with 0.25 mL DNA-RNA shield solution for the detection of Factor V Leiden and Prothrombin 20210A gene mutations using PCR Duplex Prothrombin 20210 and Factor V. Data analysis was conducted using the statistical package for social sciences (SPSS) version 17.0 software. The findings revealed that the overall mutation carriage rate (AA and AG) for the Prothrombin 20210A gene (5%) was more prevalent than FVL (3%) among the subjects. Furthermore, the mean PT and APTT (in seconds) were significantly lower (p&lt;0.001) among women using combined hormonal contraceptives. These findings suggest a potential association between the presence of FVL and FII genes mutations and thromboembolism among Nigerian women using hormonal contraceptives.</p> Obzzelu Progress Emokpae Mathias Erhabor Osaro Copyright (c) 2024 Obzzelu Progress, Emokpae Mathias, Erhabor Osaro https://creativecommons.org/licenses/by/4.0 2024-04-02 2024-04-02 10 1 1 5 10.51152/jbarbiomed.v10i1.230 Bioassay-Guided Isolation of Antimicrobial Compounds from Marine Sponge Neopetrosia exigua https://jbarbiomed.com/index.php/home/article/view/235 <p>The marine sponge <em>Neopetrosia exigua</em> has shown great potential as a source of bioactive compounds with significant antimicrobial properties. This study applied bioassay-guided fractionation to isolate and evaluate the antimicrobial activities of various compounds from <em>N. exigua</em> collected off the coast of Langkawi Island, Malaysia. Methanol extracts were partitioned into different fractions, with dichloromethane (CH₂Cl₂) and n-butanol (n-BuOH) fractions exhibiting the most potent antimicrobial activities. Four compounds were isolated: a previously undescribed bisulphate avarol derivative (<strong>1</strong>), two compounds isolated for the first time from <em>N. exigua</em> isohyrtiosine A (<strong>2</strong>) and demethylcystalgerone (<strong>3</strong>) and xestospongien (<strong>4</strong>), a known compound in <em>N. exigua</em>. The bisulphate avarol derivative (<strong>1</strong>) showed the most potent antibacterial effect, with the ability to inhibit <em>Staphylococcus aureus</em> at concentrations as low as 2.6 µg/mL, indicating its potential as a powerful antibacterial agent for drug development. Additionally, it exhibited strong bactericidal activity against <em>Bacillus cereus</em> and fungicidal activity against <em>Candida albicans</em> and <em>Cryptococcus neoformans</em>. Isohyrtiosine A (<strong>2</strong>), an indole alkaloid, exhibited moderate antimicrobial effects, while xestospongien (<strong>4</strong>) demonstrated broad-spectrum bacteriostatic activity. Demethylcystalgerone (<strong>3</strong>), a meroditerpenoid, showed selective activity against Gram-positive bacteria. These findings highlight the potential of <em>N. exigua</em> as a source of novel antimicrobial agents, particularly in combating antibiotic-resistant pathogens. Further research into the mechanisms of action and chemical diversity of sponge-derived compounds could lead to the development of new therapeutic agents for resistant infections.</p> Syed Idid Shahbudin Saad Deny Susanti Copyright (c) 2024 Syed Idid, Shahbudin Saad, Deny Susanti https://creativecommons.org/licenses/by/4.0 2024-11-30 2024-11-30 10 1 50 58 10.51152/jbarbiomed.v10i1.235 Serum Levels of Lead and Selected Acute Phase Proteins in Patients with Substance Use Disorders https://jbarbiomed.com/index.php/home/article/view/237 <p>Background: Chronic inflammation, immune system dysfunction and elevation in the levels of toxic metals such as lead (Pb) are common observations in patients with substance use disorders (SUD). However, there is little information on the acute phase profile of SUD patients with different serum levels of Pb. Therefore, serum levels of selected acute phase proteins in SUD patients with different serum levels of Pb were determined in this study. Methods: A total of 84 adults consisting of 45 patients with SUDs and 39 controls were enrolled into this case-control study. Serum levels of Pb, albumin and C-reactive protein (CRP) were determined using Atomic Absorption Spectrophotometer, bromocresol green (BCG) colorimetric method, and ELISA, respectively. Thereafter, CRP-albumin ratio (CAR) was calculated as appropriate. Results: Serum levels of Pb and albumin were significantly higher in patients with SUDs compared with the controls. Considering variation in acute phase proteins based on Pb level, the serum level of albumin was significantly lower, while the serum CRP level and CAR were slightly higher in patients with SUDs whose Pb level was higher than 5 µg/dL compared with patients whose Pb level was ≤5 µg/dL. No significant differences were observed in the levels of Pb, albumin, CRP, CAR in patients with SUDs who abuse single substance compared with those who abuse multiple substances. Conclusion: SUD is associated with increased serum levels of Pb and albumin, and alteration in the serum levels of acute phase proteins appears to be influenced by the serum Pb level. Therefore, there is the need for routine measurement of Pb level in patients with SUDs as they could benefit from therapeutic interventions involving chelation of Pb which could prevent disordered acute phase responses in the patients and facilitate optimal response to antipsychotics.</p> Sheu Rahamon Mercy Ojediran Surajudeen Yaqub James Osikorobia Oluremi Oladele Victor Lasebikan Copyright (c) 2024 Sheu Rahamon, Mercy Ojediran, Surajudeen Yaqub, James Osikorobia, Oluremi Oladele, Victor Lasebikan https://creativecommons.org/licenses/by/4.0 2024-12-18 2024-12-18 10 1 59 63 10.51152/jbarbiomed.v10i1.237 Prevalence of Salmonella and Escherichia coli and Associated Risk Factors Among Camel and Bovine Meat Slaughtered at Jigjiga Municipal Abattoir, Somali Regional State, Ethiopia https://jbarbiomed.com/index.php/home/article/view/233 <p>A cross-sectional study involving microbiological analysis was conducted from March 2021 to August 2021 in Jigjiga town to isolating and identifying Salmonella and <em>E. coli</em> from raw meats of camels and bovines slaughtered at the Jigjiga municipal abattoir and assessing possible associated related risk factors for the isolates. A total of 384 examined samples for the presence of <em>Salmonella </em>and<em> E. coli</em>. From the total samples examined, 64 (16.7%) and 44 (11.5%. were found to be <em>E. coli</em> and <em>Salmonella</em> positive respectively. Out of the 199 meat samples taken from camel, 31 (15.6%) and 32 (16.1%) were found positive for <em>Salmonella</em> and <em>E. coli</em> respectively while a total 185 meat samples of bovines, 13 (7%) and 32 (17%) were found positive for <em>Salmonella</em> and <em>E. coli,</em> respectively. In the univariable logistic regression analysis result, <em>Salmonella </em>revealed a statistically significant difference among different ages (OR (CI) = 2.36 (1.195–4.679); p-value = 0.013). The multivariable regression analysis showed there was no statistically significant difference between the two sex groups (OR (CI) = 2.01 (0.892–4.544); p = 0.092). In an univariable logistic regression analysis result, the odds of meat contamination in young-aged animals with <em>E. coli</em> were three times higher than in adult animals, showing a statistically significant difference (OR = 2.83 (1.567–5.095; p = 0.001). The prevalence of <em>E. coli</em> was higher in animals with poor body condition (31.9%), followed by medium (15.5%) and good body-conditioned animals (1.8%). In the multivariable logistic regression analysis, the odds of contamination of samples with <em>E. coli</em> from poor-body condition animals were 22 times higher than samples taken from good-body condition animals (OR (CI) = 21.8 (5.022 - 95.059); p = 0.000). To prevent cross-contamination of <em>Salmonella </em>and <em>E. coli</em>, hygiene must be improved, standardized procedures, and training programs should be implemented. Further studies on molecular characterization and serotyping of these species are also needed.</p> Mustafe Ahmed Bashir Bashir Mahamed Abdilahi Samatar Mahamed Copyright (c) 2024 Mustafe Ahmed, Bashir Bashir, Mahamed Abdilahi, Samatar Mahamed https://creativecommons.org/licenses/by/4.0 2024-08-30 2024-08-30 10 1 6 10 10.51152/jbarbiomed.v10i1.233